Palvella Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses9.3M7.1M6.5M5.1M4.1M2.5M3.2M1.4M
Operating Expenses14.9M11.3M10.2M9.3M7.9M4.4M5.1M2.9M
Operating Income-14.9M-11.3M-10.2M-9.3M-7.9M-4.4M-5.1M-2.9M
Other Income / Gains-912K-1.4M-1.2M-221K-314K415K-1.7M-1.3M
Net Income-15.8M-12.7M-11.3M-9.5M-8.2M-4.0M-6.8M-4.2M
EPS (Diluted)-1.20-1.08-1.03-0.86-3.68-0.88-2.19-3.37
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses5.5M4.2M3.6M4.1M3.8M1.8M1.9M1.5M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses5.5M4.2M3.6M4.1M3.8M1.8M1.9M1.5M
Other Expenses000000-14K0
Cost And Expenses14.9M11.3M10.2M9.3M7.9M4.4M5.1M2.9M
Interest Income1.1M520K628K690K752K0169K0
Interest Expense2.0M1.7M1.5M1.4M1.2M1.3M01.1M
Depreciation And Amortization0010.2M0005.1M0
Ebitda-17.8M-11.0M342K-8.1M-7.0M-2.6M-1.7M-3.1M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-15.8M-12.7M-11.3M-9.5M-8.2M-4.0M-6.8M-4.2M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-1.20-1.08-1.03-0.86-3.68-0.88-2.19-3.37
Weighted Average Shs Out13.1M11.3M11.1M11.1M2.2M2.2M1.3M1.3M
Weighted Average Shs Out Dil13.1M11.3M11.1M11.1M2.2M2.2M1.3M1.3M